RBM15B and neoplasm: For instance, in TGCTs, higher VIRMA expression was found to be associated with low disease stage; in addition, in KCa, RBM15B overexpression (an eraser) associated with advanced disease at diagnosis, whereas the writer METTL3 was reported to act as a tumor suppressor.